All Reports Events Blogs Videos
Showing 9 results
  • Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Thematic Report
    Nov. 03, 2020

    Digital technologies continue to dramatically reshape industries, and it is evident that the future of global services delivery is digital. Enterprises continue to invest extensively in Data and Analytics (D&A) services delivery to overhaul their existing…